16.73
price down icon1.06%   -0.18
after-market アフターアワーズ: 16.73
loading
前日終値:
$16.91
開ける:
$16.98
24時間の取引高:
263.40K
Relative Volume:
0.44
時価総額:
$861.85M
収益:
$107.46M
当期純損益:
$105.90M
株価収益率:
8.2511
EPS:
2.0276
ネットキャッシュフロー:
$238.50M
1週間 パフォーマンス:
-0.18%
1か月 パフォーマンス:
+4.43%
6か月 パフォーマンス:
+11.91%
1年 パフォーマンス:
+62.59%
1日の値動き範囲:
Value
$16.65
$17.17
1週間の範囲:
Value
$16.45
$17.17
52週間の値動き範囲:
Value
$8.33
$21.03

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
名前
Theravance Biopharma Inc
Name
セクター
Healthcare (1106)
Name
電話
650-808-6000
Name
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
職員
90
Name
Twitter
Name
次回の収益日
2026-05-14
Name
最新のSEC提出書
Name
TBPH's Discussions on Twitter

Compare TBPH vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
TBPH icon
TBPH
Theravance Biopharma Inc
16.73 871.12M 107.46M 105.90M 238.50M 2.0276
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
424.36 109.34B 12.32B 4.34B 3.19B 16.86
REGN icon
REGN
Regeneron Pharmaceuticals Inc
702.27 74.35B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
794.70 50.44B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
301.11 39.78B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
297.49 33.02B 5.36B 287.73M 924.18M 2.5229

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-05 ダウングレード Oppenheimer Outperform → Perform
2026-03-04 ダウングレード B. Riley Securities Buy → Neutral
2025-12-03 開始されました Oppenheimer Outperform
2025-09-12 開始されました B. Riley Securities Buy
2024-08-06 ダウングレード Leerink Partners Outperform → Market Perform
2024-04-12 開始されました BTIG Research Buy
2024-01-08 ダウングレード Evercore ISI Outperform → In-line
2022-05-23 開始されました SVB Leerink Outperform
2021-11-05 アップグレード JP Morgan Underweight → Neutral
2021-09-15 ダウングレード JP Morgan Overweight → Underweight
2021-08-25 ダウングレード Morgan Stanley Overweight → Underweight
2021-08-24 ダウングレード Cowen Outperform → Market Perform
2020-10-14 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-07 開始されました JP Morgan Overweight
2020-06-15 開始されました Morgan Stanley Equal-Weight
2020-05-13 開始されました Cowen Outperform
2020-01-08 繰り返されました H.C. Wainwright Buy
2019-11-06 アップグレード Robert W. Baird Underperform → Neutral
2019-10-29 開始されました H.C. Wainwright Buy
2018-03-29 再開されました Piper Jaffray Overweight
2017-08-17 開始されました Evercore ISI Outperform
2017-06-16 開始されました Cantor Fitzgerald Overweight
2017-05-11 繰り返されました Needham Buy
2016-12-21 開始されました Needham Buy
2016-11-03 開始されました Piper Jaffray Overweight
2016-10-12 ダウングレード Robert W. Baird Neutral → Underperform
2016-08-03 ダウングレード BofA/Merrill Neutral → Underperform
2016-06-20 開始されました Guggenheim Buy
2016-06-20 繰り返されました Leerink Partners Outperform
2016-05-12 開始されました Leerink Partners Outperform
2016-05-05 ダウングレード BofA/Merrill Buy → Neutral
2015-02-03 アップグレード Robert W. Baird Underperform → Neutral
すべてを表示

Theravance Biopharma Inc (TBPH) 最新ニュース

pulisher
May 05, 2026

MSN Money - MSN

May 05, 2026
pulisher
May 04, 2026

(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

May 04, 2026
pulisher
May 04, 2026

Theravance's Q4 earnings and revenues miss estimates - MSN

May 04, 2026
pulisher
May 03, 2026

Theravance stock declines around 17% in three months: Here's why - MSN

May 03, 2026
pulisher
Apr 30, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire

Apr 30, 2026
pulisher
Apr 28, 2026

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent

Apr 28, 2026
pulisher
Apr 28, 2026

Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan

Apr 28, 2026
pulisher
Apr 28, 2026

A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet

Apr 28, 2026
pulisher
Apr 27, 2026

Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Apr 25, 2026
pulisher
Apr 24, 2026

Laughing Water Capital Adds Theravance Biopharma to Portfolio in Q1 2026 - HarianBasis.co

Apr 24, 2026
pulisher
Apr 24, 2026

Laughing Water Capital’s New Position: Theravance Biopharma, Inc. (TBPH) - Insider Monkey

Apr 24, 2026
pulisher
Apr 24, 2026

Laughing Water Capital’s New Position: Theravance Biopharma (TBPH) - Yahoo Finance

Apr 24, 2026
pulisher
Apr 23, 2026

Theravance and Mylan settle patent dispute with Eugia Pharma - MSN

Apr 23, 2026
pulisher
Apr 23, 2026

How (TBPH) Movements Inform Risk Allocation Models - Stock Traders Daily

Apr 23, 2026
pulisher
Apr 23, 2026

Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat

Apr 23, 2026
pulisher
Apr 22, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 22, 2026
pulisher
Apr 21, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Reach Out - ACCESS Newswire

Apr 21, 2026
pulisher
Apr 21, 2026

Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH) - Seeking Alpha

Apr 21, 2026
pulisher
Apr 20, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Theravance Biopharma, Inc. (TBPH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Apr 20, 2026
pulisher
Apr 20, 2026

Theravance Biopharma (TBPH) Stock: What Investors Should Know (-0.75%) 2026-04-20Buy Signals - Xã Thanh Hà

Apr 20, 2026
pulisher
Apr 19, 2026

B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 - Insider Monkey

Apr 19, 2026
pulisher
Apr 19, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 19, 2026
pulisher
Apr 19, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewir - The National Law Review

Apr 19, 2026
pulisher
Apr 17, 2026

Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Apr 17, 2026
pulisher
Apr 17, 2026

Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside - DirectorsTalk Interviews

Apr 17, 2026
pulisher
Apr 16, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Investors to Connect - ACCESS Newswire

Apr 16, 2026
pulisher
Apr 16, 2026

Theravance Stock Declines Around 17% in Three Months: Here's Why - Yahoo Finance

Apr 16, 2026
pulisher
Apr 16, 2026

TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP - GlobeNewswire

Apr 16, 2026

Theravance Biopharma Inc (TBPH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$28.32
price down icon 0.14%
$50.44
price up icon 0.48%
$95.50
price down icon 3.88%
$139.44
price down icon 0.41%
$147.21
price down icon 0.47%
ONC ONC
$297.49
price up icon 0.12%
大文字化:     |  ボリューム (24 時間):